After revealing she was in remission from MS in 2021, the actor is sharing a glimpse into life with the condition.

Less frequent Ocrevus infusions are just as effective in controlling MS, but may help limit the risk of side effects, per a ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

A large majority of people with relapsing-remitting multiple sclerosis (RRMS) who received Tysabri (natalizumab) in a real-world setting experienced no evidence of disease activity for as long as ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Therapy for multiple sclerosis progression is a third major research theme. Inhibitors of Bruton's tyrosine kinase (BTK), an intracellular signalling enzyme expressed in B cells and most innate immune ...

Multiple sclerosis (MS) hip pain and knee soreness are very common problems. Joint issues are usually due to a nerve-related or muscle-related manifestation of MS rather than degeneration of cartilage ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying reasons. Is it safe? What do the data show?